Critical Questions Regarding Gadolinium Deposition in the Brain and Body After Injections of the Gadolinium-Based Contrast Agents, Safety, and Clinical Recommendations in Consideration of the EMAʼs Pharmacovigilance and Risk Assessment Committee Recommendation for Suspension of the Marketing Authorizations for 4 Linear Agents

Title

Critical Questions Regarding Gadolinium Deposition in the Brain and Body After Injections of the Gadolinium-Based Contrast Agents, Safety, and Clinical Recommendations in Consideration of the EMAʼs Pharmacovigilance and Risk Assessment Committee Recommendation for Suspension of the Marketing Authorizations for 4 Linear Agents

Authors

Keywords

-

Journal

INVESTIGATIVE RADIOLOGY

Volume 52, Issue 6, Pages 317-323

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2017-04-01

DOI

10.1097/rli.0000000000000374